How The FLT3 Mutation Influences Treatment Decisions In AML

Editor

6 years ago

James McCloskey, MD, Interim Chief, Division of Leukemia, Hackensack University Medical Center, John Theurer Cancer Center, discusses How The FLT3 Mutation Influences Treatment Decisions In AML. At The 60th ASH Annual Meeting on Dec 1, 2018. http://obroncology.com